Dr. Rabia Cheema is a Oklahoma City, Oklahoma based female rheumatologist who is specialized in Rheumatology. Active license number of Dr. Rabia Cheema for Rheumatology is 35493 in Oklahoma. Dr. Rabia Cheema treat joint disease similar to orthopedists but do not perform surgeries. She diagnose and treat diseases of joints, muscle, bones and tendons which includes arthritis, back pain, muscle strains, common athletic injuries and 'collagen' diseases.
Complete Profile:
Dr. Rabia Cheema speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Rheumatology
Credentials:
M.D.
Gender:
Female
Practice Address:
13401 N Western Ave, Oklahoma City, Oklahoma, 73114
Phone:
405-272-4953
Fax:
405-272-4956
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1295174431
NPI Enumeration Date:
20 Jun, 2013
NPI Last Update On:
17 Oct, 2022
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Rabia Cheema are as mentioned below.
License Number
Specialization
State
Status
35493
Rheumatologist
Oklahoma
Primary
55302
Internal Medicine
Connecticut
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
13401 N Western Ave, Oklahoma City, Oklahoma
Zip:
73114-1408
Phone Number:
405-272-4953
Fax Number:
405-272-4956
Patients can reach Dr. Rabia Cheema at 13401 N Western Ave, Oklahoma City, Oklahoma or can call to book an appointment on 405-272-4953. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.